Evidence map›Paper›PMID 32175843›Full record

ArticleeLife2020

PACT-mediated PKR activation acts as a hyperosmotic stress intensity sensor weakening osmoadaptation and enhancing inflammation.

Kenneth T Farabaugh, Dawid Krokowski, Bo-Jhih Guan, Zhaofeng Gao, Xing-Huang Gao, Jing Wu, Raul Jobava, Greeshma Ray, Tristan J de Jesus, Massimiliano G Bianchi and 10 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Luteolin protects DYT-Frontiers in pharmacology · 2023
    Article
  14. Review
  15. Article
  16. dsRNA-induced condensation of antiviral proteins modulates PKR activity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Kenneth T FarabaughDepartment of Pharmacology, Case Western Reserve University, Cleveland, United States.ORCID 0000-0002-9591-0466
Dawid KrokowskiDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.
Bo-Jhih GuanDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.
Zhaofeng GaoDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.
Xing-Huang GaoDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.ORCID 0000-0002-0720-3690
Jing WuDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.
Raul JobavaDepartment of Biochemistry, Case Western Reserve University, Cleveland, United States.
Greeshma RayDepartment of Inflammation and Immunity, Cleveland Clinic Foundation, Cleveland, United States.
Tristan J de JesusDepartment of Pathology, Case Western Reserve University, Cleveland, United States.
Massimiliano G BianchiDepartment of Medicine and Surgery, Universita degli Studi di Parma, Parma, Italy.
Evelyn ChukwurahDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.
Ovidio BussolatiDepartment of Medicine and Surgery, Universita degli Studi di Parma, Parma, Italy.ORCID 0000-0002-4301-2939
Michael KilbergDepartment of Biochemistry and Molecular Biology, University of Florida, Gainesville, United States.
David A BuchnerDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.ORCID 0000-0003-3920-4871
Ganes C SenDepartment of Inflammation and Immunity, Cleveland Clinic Foundation, Cleveland, United States.
Calvin CottonDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, United States.
Christine McDonaldDepartment of Inflammation and Immunity, Cleveland Clinic Foundation, Cleveland, United States.
Michelle LongworthDepartment of Inflammation and Immunity, Cleveland Clinic Foundation, Cleveland, United States.
Parameswaran RamakrishnanDepartment of Pathology, Case Western Reserve University, Cleveland, United States.ORCID 0000-0002-1314-827X
Maria HatzoglouDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, United States.ORCID 0000-0003-2037-1231
Case Western Reserve University · USCleveland Clinic · USUniversity of Parma · ITMaria Curie-Skłodowska University · PLUniversity of Florida · US

Funding

TELOMERASE INACTIVATION BY RNASE L SIGNALS CELL DEATHP01CA062220 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI LI, XIAOXIA, STARK, GEORGE ROBERT · 1994 to 2020
$35.6M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI AMITABH CHAK · 2015 to 2026
$15.6M
Regulation of Gene Expression During StressR01DK053307 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI HATZOGLOU, MARIA · 1998 to 2021
$9.6M
Translational Control by NutrientsR01DK060596 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI MARIA HATZOGLOU · 2002 to 2026
$6.3M
Sarcopenia in cirrhosis is mediated by a hyperammonemic stress responseR01DK113196 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, HATZOGLOU, MARIA · 2018 to 2021
$2.3M
Transcriptional regulation by O-GlcNAcylation in T lymphocytesR01AI116730 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI RAMAKRISHNAN, PARAMESWARAN · 2016 to 2020
$2.0M
Regulation of B cell function and antibody class switching by c-Rel O-GlcNAcylationR21AI144264 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI RAMAKRISHNAN, PARAMESWARAN · 2019 to 2020
$441k
NCI NIH HHS P01 CA062220NIAID NIH HHS R01 AI116730NIAID NIH HHS R21 AI144264NIDDK NIH HHS P30 DK097948NIDDK NIH HHS R01 DK053307NIDDK NIH HHS R01 DK060596NIDDK NIH HHS R01 DK113196
6 · The paper itself

Abstract

The inability of cells to adapt to increased environmental tonicity can lead to inflammatory gene expression and pathogenesis. The Rel family of transcription factors TonEBP and NF-κB p65 play critical roles in the switch from osmoadaptive homeostasis to inflammation, respectively. Here we identified PACT-mediated PKR kinase activation as a marker of the termination of adaptation and initiation of inflammation in

Indexed as

Osmotic PressureAdaptation, PhysiologicalAnimalsCarrier ProteinsCell LineeIF-2 KinaseGene Expression RegulationHumansMiceNF-kappa BProto-Oncogene Proteins c-relRNA-Binding ProteinsRNA InterferenceSignal TransductionCarrier ProteinsEIF2AK2 protein, humaneIF-2 KinaseNF-kappa BPRKRA protein, humanprotein kinase R, mouseProto-Oncogene Proteins c-relRbbp6 protein, mouseRNA-Binding ProteinsgeneticsgenomicsHyperosmotic stressimmunologyinflammationmouseNF-κB c-RelNF-κB p65PACTPKRTonEBP

Identifiers

PMID32175843
PMCPMC7145421
OpenAlexW3011033051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.